Your browser doesn't support javascript.
loading
Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice.
Itoh, N; Imagawa, A; Hanafusa, T; Waguri, M; Yamamoto, K; Iwahashi, H; Moriwaki, M; Nakajima, H; Miyagawa, J; Namba, M; Makino, S; Nagata, S; Kono, N; Matsuzawa, Y.
Afiliación
  • Itoh N; Department of Clinical Laboratory Science, School of Allied Health Sciences, Faculty of Medicine, Osaka University, Suita, Osaka 565, Japan. nitoh@sahs.med.osaka-u.ac.jp
J Exp Med ; 186(4): 613-8, 1997 Aug 18.
Article en En | MEDLINE | ID: mdl-9254659
Insulin-dependent diabetes mellitus (IDDM) is assumed to be a T cell-mediated autoimmune disease. To investigate the role of Fas-mediated cytotoxicity in pancreatic beta cell destruction, we established nonobese diabetic (NOD)-lymphoproliferation (lpr)/lpr mice lacking Fas. Out of three genotypes, female NOD-+/+ and NOD-+/lpr developed spontaneous diabetes by the age of 10 mo with the incidence of 68 and 62%, respectively. In contrast, NOD-lpr/lpr did not develop diabetes or insulitis. To further explore the role of Fas, adoptive transfer experiments were performed. When splenocytes were transferred from diabetic NOD, male NOD-+/+ and NOD-+/lpr developed diabetes with the incidence of 89 and 83%, respectively, whereas NOD-lpr/lpr did not show glycosuria by 12 wk after transfer. Severe mononuclear cell infiltration was revealed in islets of NOD-+/+ and NOD-+/lpr, whereas islet morphology remained intact in NOD-lpr/lpr. These results suggest that Fas-mediated cytotoxicity is required to initiate beta cell autoimmunity in NOD mice. Fas-Fas ligand system might be critical for autoimmune beta cell destruction leading to IDDM.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor fas / Diabetes Mellitus Tipo 1 Límite: Animals Idioma: En Revista: J Exp Med Año: 1997 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptor fas / Diabetes Mellitus Tipo 1 Límite: Animals Idioma: En Revista: J Exp Med Año: 1997 Tipo del documento: Article País de afiliación: Japón